May 6, 2011 – The report recommends training focused on three levels of competency based on the individual interventional cardiologist's level of experience with simple and complex cases, including patients with challenging anatomy.
In a move that will likely have a significant impact how many patients are treated for carotid artery disease, the U.S. Food and Drug Administration (FDA) has cleared the use of a stent to treat standard-risk surgical patients. Prior to the approval, carotid stenting was only indicated for used in high-risk surgical patients who were often denied the standard-of-care of carotid endarterectomy surgery.
May 6, 2011 – New data presented at the Society for Cardiovascular Angiography and Interventions (SCAI) Scientific Sessions are the first to look at the use of highly specialized signals within implantable cardioverter defibrillators (ICDs) to detect restricted blood flow to the heart in high-risk cardiovascular disease patients outside the hospital setting. Preliminary results from the ST-DETECT Trial using high-fidelity intracardiac electrogram (EGM) signals in ICDs show a low spontaneous coronary event rate (such as heart attack) among these patients.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
May 6, 2011 – A substance secreted by the heart that is associated with congestive heart failure and renal failure is not predictive of reduction in systolic blood pressure in patients treated with renal artery stenting, according to results from the HERCULES trial. Data was presented as a late-breaking clinical trial at the Society for Cardiovascular Angiography and Interventions (SCAI) 2011 Scientific Sessions in Baltimore.
May 6, 2011 – African American patients who undergo angioplasty and stenting fare worse over the long run than patients of other races, regardless of socioeconomic status. In fact, the risk of dying within about three years is more than twice as high among African Americans, according to a study presented today at the Society for Cardiovascular Angiography and Interventions (SCAI) 2011 Scientific Sessions.
May 6, 2011 – Results from an analysis of the ALTITUDE Clinical Science program demonstrated that defibrillator therapy saves lives from lethal arrhythmias without an increase in mortality due to defibrillator shock. Instead, the authors found that increased mortality risk associated with these shocks is not attributed to the defibrillator shock itself, but rather to the underlying medical condition leading to atrial and ventricular arrhythmias.
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
May 6, 2011 – Functionality in the echo ultrasound market drives satisfaction as providers push the bounds of what the technology can do to treat an increasing number of patients at risk for cardiovascular disease. Vendors have responded to these demands with new systems and new technology over the last couple of years.
May 5, 2011 – Volcano Corp. announced a supply agreement with ev3, a Covidien company, under which Volcano will supply its intravascular ultrasound (IVUS) technology for use in ev3's Plaque Excision Systems. Utilizing the digital IVUS transducer incorporated in Volcano's EagleEye catheter product line, this new product will be capable of running on Volcano's global installed base of 5,000 systems.
May 5, 2011 – A new warranty program is available in the United States that covers Boston Scientific’s cardiac resynchronization defibrillator (CRT-D) devices and leads in the event of chronic phrenic nerve stimulation (PNS).
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
May 5, 2011 – GE Healthcare is showing a complete portfolio of integrated electrophysiology (EP) products featuring electrical signals recording and anatomical imaging at the lowest dose, 3-D rotational angiography capabilities, and components integration.
May 5, 2011 – GE scientists are already studying additive manufacturing techniques to reduce labor and costs on ultrasound devices. Here, the key aspect is the transducer, which is expensive to produce using current manufacturing techniques.
May 4, 2011 – A new version of the Liberator Locking Stylet uses a distinct radiopaque tip marker to increase radio-opacity under fluoroscopy.
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
May 4, 2011 – Doctors should consider using catheterization as a treatment tool in addition to its established role in diagnosing children with heart defects, according to a new American Heart Association scientific statement.
May 4, 2011 – At Heart Rhythm 2011, the Heart Rhythm Society’s 32nd annual scientific sessions in San Francisco, Royal Philips Electronics and the Heart Rhythm Society (HRS) have teamed up to showcase current solutions and future developments that shape the diagnosis and minimally invasive treatment of heart rhythm disorders.
May 4, 2011 – Endosense and Siemens Healthcare have completed a prototype software software software integrating the contact-force data provided by Endosense’s TactiCath force-sensing ablation catheter1 with Siemens’ electrophysiology solutions.